InvestorsHub Logo
Followers 7
Posts 591
Boards Moderated 0
Alias Born 04/18/2005

Re: biopharm post# 279598

Saturday, 11/26/2016 2:20:11 PM

Saturday, November 26, 2016 2:20:11 PM

Post# of 346182
...and we haven't heard boo about the number of patients in the "control group" that left for newer therapies when the data was presented. Why is that?

I find it almost impossible that the control group just happened to have an incredible outcome without such a variable added to the equation.

They have to know the statistical facts related to that the control group of the phase 3...How many left and how did it positively impact their survival?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News